D(+)-α-甲基苄胺，CAS 登记号 3886-69-9，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 D(+)-α-甲基苄胺 的 CAS 号：3886-69-9，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
D(+)-alpha-Methylbenzylamine · CAS 3886-69-9 · C8H11N. UNII V022ZK8GZ5.
| CAS Registry Number | 3886-69-9 |
|---|---|
| PubChem CID | 643189 |
| Molecular formula | C8H11N |
| IUPAC name | (1R)-1-phenylethanamine |
| UNII (FDA) | V022ZK8GZ5 |
| Molecular Weight | 121.18 |
|---|---|
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 121.089149355 |
| Monoisotopic Mass | 121.089149355 |
| Topological Polar Surface Area | 26 |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (98.8%), H312 (97.7%), H314 (100%), H318 (65.1%) |
|---|
H302 (98.8%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (97.7%): Harmful in contact with skin [Warning Acute toxicity, dermal]
3886-69-9; (R)-(+)-1-Phenylethylamine; (R)-(+)-alpha-Methylbenzylamine; D-alpha-Methylbenzylamine; 1-Phenethylamine, (+)-; d-1-phenylethylamine; V022ZK8GZ5; r-(+)-methylbenzylamine; EINECS 223-423-4; Benzenemethanamine, .alpha.-methyl-, (.alpha.R)-; (r)-(+)-1-phenethylamine; D-.ALPHA.-PHENETHYLAMINE; Benzenemethanamine, alpha-methyl-, (alphaR)-; DTXSID80930735; EC 223-423-4; D-.ALPHA.-METHYLBENZYLAMINE
CAS 3886-69-9; molecular formula C8H11N; molecular weight — g/mol.
3886-69-9, (R)-(+)-1-Phenylethylamine, (R)-(+)-alpha-Methylbenzylamine, D-alpha-Methylbenzylamine, 1-Phenethylamine, (+)-, d-1-phenylethylamine.
Hazard statements reported: H302, H312, H314, H318.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.